Table 2.
Results of the control group with the 3 study groups
| Study groups | Control | Levosimendan | Dobutamine | Dobutamine+Levosimendan |
|---|---|---|---|---|
| Initial QRS > 20% (s) |
162 (101-342) |
173 (103-403) |
153 (105-410) |
159 (90-432) |
| Initial arrhythmia (s) |
203 (129-549) |
455 (153-850) |
448 (249-1367) |
310 (97-567) |
| Heart rate < 50% (s) |
345 (214-583) |
903* (301-1848) |
984 *(672-2814) |
1705 †* (1039-3009) |
| Heart rate < %75 (s) |
538 (353-961) |
1198* (358-7014) |
1542 * (895-4092 |
3152 †* (1747-6519 |
| Mean arterial pressure < %50 (s) |
399 (245-665) |
1005* (243-1592) |
685* (514-1992) |
1544 †* (874-3003) |
| Mean arterial pressure < %75 (s) |
504 (381-814) |
1204* (298-6028) |
1009* (698-4013) |
2982 †* (1542-6897) |
| Cardiac arrest time (s) |
703 (403-1049) |
1385* (412-6552) |
1789 * (944-4742) |
3357 †* (1825-7200) |
| Total Bupivacaine dose (μg) | 8.48 (5.03-13.11) | 17.62 * (5.15-90.0) | 22.36 * (11.80-59.20) | 41.90 †* (22.80-90.0) |
Data is given as median with minimum and maximum values.
*p < 0.05 compared to the control group, †p < 0.008 for pairwise comparison of all 4 groups.